Global Cord Blood Profit Margin

Global Cord Blood posts a profit margin of 38.59% as of July 2022. That compares with 42.9% in the prior-year period — down 10.0% year over year. That is above the Healthcare sector average of 13.76%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Global Cord Blood's profit margin was 42.9%. The latest reading is 38.59% — a 10.0% year-over-year decrease (period ending July 2022). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 13.76% is typical. Global Cord Blood's 38.59% is higher that level. That is roughly 180.4% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Global Cord Blood's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 38.59% as of July 2022; use YoY and peer views to separate noise from signal.

Context for CO's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.76%), and (3) consistency with growth and profitability. This page covers the first two; Global Cord Blood's other metric pages and overview cover the third.